human alpha1-proteinase inhibitor
PolandMedications containing this active substance
-
Rymphysia
Form: powder and solvent for preparation of concentrate for infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 500 mg ATC: B02AB02
Manufacturer: Takeda Manufacturing Austria AG
-
Rymphysia
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 1000 mg ATC: B02AB02
Manufacturer: Takeda Manufacturing Austria AG